CHI Health Saint Francis Saint Francis Alc and Drug Trt Center

CHI Health Saint Francis Saint Francis Alc and Drug Trt Center is a SAMHSA-registered addiction-treatment facility in Grand Island, NE. The facility offers a continuum of care across multiple levels — Inpatient, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at CHI Health Saint Francis Saint Francis Alc and Drug Trt Center

On care levels: The facility offers a continuum of care across multiple levels — Inpatient, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. The critical pre-admission step is an independent clinical assessment that establishes ASAM 4e level-of-care recommendation. Admission at a facility whose offered level does not match the clinical assessment produces most misaligned-placement outcomes.

Insurance and payment

CHI Health Saint Francis Saint Francis Alc and Drug Trt Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Before you call

Three pre-admission questions for CHI Health Saint Francis Saint Francis Alc and Drug Trt Center: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.